MA43978A - Dérivé de sulfonamide hétérocyclique et médicament le contenant - Google Patents
Dérivé de sulfonamide hétérocyclique et médicament le contenantInfo
- Publication number
- MA43978A MA43978A MA043978A MA43978A MA43978A MA 43978 A MA43978 A MA 43978A MA 043978 A MA043978 A MA 043978A MA 43978 A MA43978 A MA 43978A MA 43978 A MA43978 A MA 43978A
- Authority
- MA
- Morocco
- Prior art keywords
- product containing
- medicinal product
- sulfonamide derivative
- heterocyclic sulfonamide
- heterocyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016021358 | 2016-02-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43978A true MA43978A (fr) | 2018-12-12 |
Family
ID=59499709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043978A MA43978A (fr) | 2016-02-05 | 2017-02-03 | Dérivé de sulfonamide hétérocyclique et médicament le contenant |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10584116B2 (de) |
| EP (1) | EP3412664B1 (de) |
| JP (1) | JP6906449B2 (de) |
| KR (1) | KR20180104150A (de) |
| CN (1) | CN108602807B (de) |
| AU (1) | AU2017213993B2 (de) |
| CA (1) | CA3012812A1 (de) |
| DK (1) | DK3412664T3 (de) |
| EA (1) | EA037264B1 (de) |
| ES (1) | ES2911416T3 (de) |
| MA (1) | MA43978A (de) |
| MX (1) | MX2018009458A (de) |
| PL (1) | PL3412664T3 (de) |
| WO (1) | WO2017135462A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7043483B2 (ja) * | 2016-07-20 | 2022-03-29 | エフ．ホフマン－ラ ロシュ アーゲー | 二環式プロリン化合物 |
| FR3114235A1 (fr) | 2020-09-18 | 2022-03-25 | Université Grenoble Alpes | Inhibition du canal trpa1 astrocytaire comme nouvelle cible therapeutique neuroprotectrice dans les phases prodromales de la maladie d’alzheimer |
| IT202100015098A1 (it) | 2021-06-09 | 2022-12-09 | Flonext S R L | Composto antagonista del canale trpa1 per uso in patologie degenerative della retina |
| WO2023033097A1 (ja) * | 2021-09-02 | 2023-03-09 | Ｅａファーマ株式会社 | 複素環スルホンアミド誘導体の製造方法、およびその合成中間体 |
| WO2024099403A1 (zh) * | 2022-11-10 | 2024-05-16 | 北京普祺医药科技股份有限公司 | 一种具有软药性质的硫醚类化合物、药物组合物及其用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8017612B2 (en) * | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| US8614201B2 (en) | 2009-06-05 | 2013-12-24 | Janssen Pharmaceutica Nv | Heterocyclic amides as modulators of TRPA1 |
| EP2520566A1 (de) * | 2011-05-06 | 2012-11-07 | Orion Corporation | Neue pharmazeutische Verbindungen |
| WO2013108857A1 (ja) | 2012-01-17 | 2013-07-25 | 味の素株式会社 | 複素環アミド誘導体及びそれを含有する医薬 |
| KR20150061647A (ko) | 2012-09-27 | 2015-06-04 | 에프. 호프만-라 로슈 아게 | 치환된 설폰아미드 화합물 |
| EP2937335A4 (de) | 2012-12-18 | 2016-09-14 | Ea Pharma Co Ltd | Heterocyclisches amidderivat sowie medikament damit |
| EP2774919A1 (de) | 2013-03-06 | 2014-09-10 | Pharmeste S.R.L. In Liquidazione | Neuartige Sulfonamid-TRPA1-Rezeptorantagnonisten |
| LT3055302T (lt) * | 2013-10-11 | 2019-03-12 | F. Hoffmann-La Roche Ag | Pakeistieji heterocikliniai sulfonamidiniai junginiai, tinkami naudoti kaip trpa1 moduliatoriai |
| RU2016134749A (ru) | 2014-01-28 | 2018-03-02 | ЕА Фарма Ко., Лтд. | Гетероциклическое сульфонамидное производное и лекарственное средство, содержащее такое производное |
| JP6700291B2 (ja) * | 2015-02-15 | 2020-05-27 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | １−（ｈｅｔ）アリールスルホニル−（ピロリジン又はピペリジン）−２−カルボキサミド誘導体、及びｔｒｐａ１拮抗薬としてのそれらの使用 |
| WO2017018495A1 (ja) * | 2015-07-29 | 2017-02-02 | Ｅａファーマ株式会社 | シクロプロパン誘導体及びそれを含有する医薬 |
-
2017
- 2017-02-03 CN CN201780009998.3A patent/CN108602807B/zh active Active
- 2017-02-03 CA CA3012812A patent/CA3012812A1/en active Pending
- 2017-02-03 AU AU2017213993A patent/AU2017213993B2/en active Active
- 2017-02-03 ES ES17747613T patent/ES2911416T3/es active Active
- 2017-02-03 EP EP17747613.2A patent/EP3412664B1/de active Active
- 2017-02-03 KR KR1020187025206A patent/KR20180104150A/ko not_active Application Discontinuation
- 2017-02-03 MX MX2018009458A patent/MX2018009458A/es unknown
- 2017-02-03 JP JP2017565677A patent/JP6906449B2/ja active Active
- 2017-02-03 PL PL17747613T patent/PL3412664T3/pl unknown
- 2017-02-03 DK DK17747613.2T patent/DK3412664T3/da active
- 2017-02-03 WO PCT/JP2017/004134 patent/WO2017135462A1/ja active Application Filing
- 2017-02-03 EA EA201891782A patent/EA037264B1/ru unknown
- 2017-02-03 MA MA043978A patent/MA43978A/fr unknown
-
2018
- 2018-08-03 US US16/054,077 patent/US10584116B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112018015851A2 (pt) | 2018-12-26 |
| EP3412664A4 (de) | 2019-10-16 |
| CN108602807A (zh) | 2018-09-28 |
| AU2017213993B2 (en) | 2021-03-25 |
| WO2017135462A1 (ja) | 2017-08-10 |
| JPWO2017135462A1 (ja) | 2018-12-13 |
| EP3412664B1 (de) | 2022-03-30 |
| US10584116B2 (en) | 2020-03-10 |
| EA037264B1 (ru) | 2021-03-01 |
| CN108602807B (zh) | 2022-05-13 |
| MX2018009458A (es) | 2018-09-21 |
| ES2911416T3 (es) | 2022-05-19 |
| PL3412664T3 (pl) | 2022-06-06 |
| CA3012812A1 (en) | 2017-08-10 |
| US20190023699A1 (en) | 2019-01-24 |
| EA201891782A1 (ru) | 2019-06-28 |
| AU2017213993A1 (en) | 2018-09-13 |
| JP6906449B2 (ja) | 2021-07-21 |
| EP3412664A1 (de) | 2018-12-12 |
| KR20180104150A (ko) | 2018-09-19 |
| DK3412664T3 (da) | 2022-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3412660T3 (da) | Sulfonamidderivat og farmaceutisk sammensætning indeholdende samme | |
| MA49715A (fr) | Oligomères et conjugués d'oligomères | |
| EP3101015A4 (de) | Heterocyclisches sulfonamidderivat und medikament damit | |
| MA43978A (fr) | Dérivé de sulfonamide hétérocyclique et médicament le contenant | |
| DK3532029T3 (da) | Flydende farmaceutisk sammensætning | |
| DK3634377T3 (da) | Farmaceutisk formulering | |
| DK3255042T3 (da) | Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme | |
| MA46867A (fr) | Formulations pharmaceutiques | |
| MA45187A (fr) | Combinaisons pharmaceutiques | |
| MA43705A (fr) | Formulation pharmaceutique | |
| CL2019000563S1 (es) | Envase y dispendio de medicamentos. (divisional solicitud 201800718) | |
| MA44987A (fr) | Formulations de médicaments améliorées | |
| DK3426681T3 (da) | Åbne hla-b57-konformere | |
| MA40524A (fr) | Dérivés d'adrénomédulline stabilisés et leur utilisation | |
| DK3601277T3 (da) | Farmaceutisk formulering | |
| MA45457A (fr) | Médicament ophtalmique contenant du salbutamol. | |
| DK3432887T3 (da) | Anti-tuberkulosemiddel | |
| DK3453390T3 (da) | Farmaceutisk sammensætning indeholdende polymeriseret lægemiddel | |
| MA46642A (fr) | Promédicaments d'inhibiteurs de la kallicréine | |
| ES1146009Y (es) | Máquina desemblistadora de pastillas y similares | |
| EP3134392A4 (de) | Sulfonamidderivate und pharmazeutische anwendungen davon | |
| DK3153163T3 (da) | Farmaceutisk forbindelse der omfatter 13 glycerider, formulering og anvendelse deraf | |
| IL279928A (en) | History of heterocyclic sulfonamides and their pharmaceutical uses | |
| UA37078S (uk) | Розгортка упаковки фармацевтичного засобу | |
| CL2017002185S1 (es) | Tableta farmacéutica |